Cargando…

Polygenic risk scores for major depressive disorder and neuroticism as predictors of antidepressant response: Meta-analysis of three treatment cohorts

There are currently no reliable approaches for correctly identifying which patients with major depressive disorder (MDD) will respond well to antidepressant therapy. However, recent genetic advances suggest that Polygenic Risk Scores (PRS) could allow MDD patients to be stratified for antidepressant...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ward, Joey, Graham, Nicholas, Strawbridge, Rona J., Ferguson, Amy, Jenkins, Gregory, Chen, Wenan, Hodgson, Karen, Frye, Mark, Weinshilboum, Richard, Uher, Rudolf, Lewis, Cathryn M., Biernacka, Joanna, Smith, Daniel J.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2018
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6150505/ https://www.ncbi.nlm.nih.gov/pubmed/30240446 http://dx.doi.org/10.1371/journal.pone.0203896

Ejemplares similares

Affective wellbeing moderates the association between polygenic risk score for neuroticism and change in neuroticism
por: Bahbouhová, J., et al.
Publicado: (2023)

Novel genome-wide associations for anhedonia, genetic correlation with psychiatric disorders, and polygenic association with brain structure
por: Ward, Joey, et al.
Publicado: (2019)

SNP-based heritability estimates of the personality dimensions and polygenic prediction of both neuroticism and major depression: findings from CONVERGE
por: Docherty, A R, et al.
Publicado: (2016)

Polygenic risk of major depressive disorder as a risk factor for venous thromboembolism
por: Ward, Joey, et al.
Publicado: (2023)

Genome-wide approaches to antidepressant treatment: working towards understanding and predicting response
por: Hodgson, Karen, et al.
Publicado: (2012)

Polygenic risk for autism, attention deficit hyperactivity disorder, schizophrenia, major depressive disorder, and neuroticism are associated with experience of childhood abuse
por: Ratanatharathorn, Andrew, et al.
Publicado: (2021)

Antidepressant drug-specific prediction of depression treatment outcomes from genetic and clinical variables
por: Iniesta, Raquel, et al.
Publicado: (2018)

Pharmacogenomics‐Driven Prediction of Antidepressant Treatment Outcomes: A Machine‐Learning Approach With Multi‐trial Replication
por: Athreya, Arjun P., et al.
Publicado: (2019)

Identification of novel genome-wide associations for suicidality in UK Biobank, genetic correlation with psychiatric disorders and polygenic association with completed suicide
por: Strawbridge, Rona J., et al.
Publicado: (2019)

Highly polygenic architecture of antidepressant treatment response: Comparative analysis of SSRI and NRI treatment in an animal model of depression
por: Malki, Karim, et al.
Publicado: (2016)

Polygenic heterogeneity in antidepressant treatment and placebo response
por: Nøhr, Anne Krogh, et al.
Publicado: (2022)

Prospects for using risk scores in polygenic medicine
por: Lewis, Cathryn M., et al.
Publicado: (2017)

Meta-analysis of CYP2C19 and CYP2D6 metabolic activity on antidepressant response from 13 clinical studies
por: Li, Danyang, et al.
Publicado: (2023)

Improved Antidepressant Remission in Major Depression via a Pharmacokinetic Pathway Polygene Pharmacogenetic Report
por: Singh, Ajeet B.
Publicado: (2015)

A polygenic predictor of treatment-resistant depression using whole exome sequencing and genome-wide genotyping
por: Fabbri, Chiara, et al.
Publicado: (2020)

Identifying the Common Genetic Basis of Antidepressant Response
por: Pain, Oliver, et al.
Publicado: (2021)

PRSice: Polygenic Risk Score software
por: Euesden, Jack, et al.
Publicado: (2015)

Genome-Wide Association Study of Circadian Rhythmicity in 71,500 UK Biobank Participants and Polygenic Association with Mood Instability
por: Ferguson, Amy, et al.
Publicado: (2018)

Polygenic risk scores: from research tools to clinical instruments
por: Lewis, Cathryn M., et al.
Publicado: (2020)

Network science approach elucidates integrative genomic-metabolomic signature of antidepressant response and lifetime history of attempted suicide in adults with major depressive disorder
por: Grant, Caroline W., et al.
Publicado: (2022)

Functional magnetic resonance imaging data for the association between polygenic risk scores for neuroticism and reward-punishment processing
por: Park, Heekyeong, et al.
Publicado: (2022)

A large-scale polygenic risk score analysis identified candidate proteins associated with anxiety, depression and neuroticism
por: Cheng, Bolun, et al.
Publicado: (2022)

Polygenic interactions with environmental adversity in the aetiology of major depressive disorder
por: Mullins, N., et al.
Publicado: (2016)

Detecting Associations between Major Depressive Disorder Treatment and Essential Hypertension using Electronic Health Records
por: Pathak, Jyotishman, et al.
Publicado: (2014)

Polygenic risk for circulating reproductive hormone levels and their influence on hippocampal volume and depression susceptibility
por: Smeeth, Demelza M., et al.
Publicado: (2019)

ERICH3: vesicular association and antidepressant treatment response
por: Liu, Duan, et al.
Publicado: (2020)

Polygenic risk scores of lithium response and treatment resistance in major depressive disorder
por: Xiong, Ying, et al.
Publicado: (2023)

Depressive symptoms and neuroticism-related traits are the main factors associated with wellbeing independent of the history of lifetime depression in the UK Biobank
por: Fabbri, Chiara, et al.
Publicado: (2023)

Neuroticism Predicts Subsequent Risk of Major Depression for Whites but Not Blacks
por: Assari, Shervin
Publicado: (2017)

Dissecting clinical heterogeneity of bipolar disorder using multiple polygenic risk scores
por: Coombes, Brandon J., et al.
Publicado: (2020)

Testing relationships between multimodal modes of brain structural variation and age, sex and polygenic scores for neuroticism in children and adolescents
por: Norbom, Linn B., et al.
Publicado: (2020)

Association of the Polygenic Scores for Personality Traits and Response to Selective Serotonin Reuptake Inhibitors in Patients with Major Depressive Disorder
por: Amare, Azmeraw T., et al.
Publicado: (2018)

Prediction of short-term antidepressant response using probabilistic graphical models with replication across multiple drugs and treatment settings
por: Athreya, Arjun P., et al.
Publicado: (2021)

Multi-omics driven predictions of response to acute phase combination antidepressant therapy: a machine learning approach with cross-trial replication
por: Joyce, Jeremiah B., et al.
Publicado: (2021)

Childhood trajectories of internalising and externalising problems associated with a polygenic risk score for neuroticism in a UK birth cohort study
por: Costantini, Ilaria, et al.
Publicado: (2023)

Genetic relationships between suicide attempts, suicidal ideation and major psychiatric disorders: A genome-wide association and polygenic scoring study
por: Mullins, Niamh, et al.
Publicado: (2014)

Genome-wide analysis in UK Biobank identifies four loci associated with mood instability and genetic correlation with major depressive disorder, anxiety disorder and schizophrenia
por: Ward, Joey, et al.
Publicado: (2017)

The relationship between neuroticism, major depressive disorder and comorbid disorders in Chinese women
por: Xia, Jing, et al.
Publicado: (2011)

Genetic Predictors of Response to Serotonergic and Noradrenergic Antidepressants in Major Depressive Disorder: A Genome-Wide Analysis of Individual-Level Data and a Meta-Analysis
por: Tansey, Katherine E., et al.
Publicado: (2012)

Telomere Length Associations With Clinical Diagnosis, Age, and Polygenic Risk Scores for Anxiety Disorder, Depression, and Bipolar Disorder
por: Mutz, Julian, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_d3utlqk5olr077fqgpoqnvmnte